Revefenacin (Yupelri) for the Treatment of Chronic Obstructive Pulmonary Disease.
作者信息
Wilkinson Joanne, Tutalo Ronald
机构信息
Brown University, Pawtucket, RI, USA.
Rhode Island Primary Care Physicians Corporation, Cranston, RI, USA.
出版信息
Am Fam Physician. 2020 Jan 15;101(2):121-122.
PMID:31939643
Abstract
摘要
相似文献
1
Revefenacin (Yupelri) for the Treatment of Chronic Obstructive Pulmonary Disease.维兰特罗（尤倍罗）用于治疗慢性阻塞性肺疾病
Am Fam Physician. 2020 Jan 15;101(2):121-122.
2
Cardiovascular safety of revefenacin, a once-daily, lung-selective, long-acting muscarinic antagonist for nebulized therapy of chronic obstructive pulmonary disease: Evaluation in phase 3 clinical trials.雷夫伐秦（一种每日一次、肺部选择性、长效毒蕈碱拮抗剂）雾化治疗慢性阻塞性肺疾病的心血管安全性：III 期临床试验评估。
Pulm Pharmacol Ther. 2019 Aug;57:101808. doi: 10.1016/j.pupt.2019.101808. Epub 2019 May 30.
3
Revefenacin for the treatment of chronic obstructive pulmonary disease.瑞福纳嗪治疗慢性阻塞性肺疾病。
Expert Rev Respir Med. 2020 Mar;14(3):239-247. doi: 10.1080/17476348.2020.1703676. Epub 2019 Dec 25.
4
Revefenacin (Yupelri) for COPD.
Med Lett Drugs Ther. 2019 Jan 28;61(1564):14-15.
5
Pharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD): Results of two randomized, double-blind, phase 2 studies.长效毒蕈碱拮抗剂 TD-4208 治疗慢性阻塞性肺疾病（COPD）患者的药效学、药代动力学和安全性：两项随机、双盲、2 期研究结果。
Pulm Pharmacol Ther. 2018 Feb;48:71-79. doi: 10.1016/j.pupt.2017.10.003. Epub 2017 Oct 4.
6
Emerging Treatments for COPD: Evidence to Date on Revefenacin.COPD 的新兴治疗方法：瑞氟米特的现有证据。
COPD. 2020 Feb;17(1):112-119. doi: 10.1080/15412555.2019.1702010. Epub 2019 Dec 13.
7
Population Pharmacokinetics of Revefenacin in Patients with Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病患者瑞夫菲那辛的群体药代动力学。
Clin Pharmacokinet. 2021 Mar;60(3):391-401. doi: 10.1007/s40262-020-00938-3.
8
Phenotype/endotype-driven therapy in COPD: potential economic implications.慢性阻塞性肺疾病中基于表型/内型的治疗：潜在的经济影响
Expert Rev Pharmacoecon Outcomes Res. 2013 Aug;13(4):421-3. doi: 10.1586/14737167.2013.815402.
9
Drugs for chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病的药物。
Treat Guidel Med Lett. 2007 Nov;5(63):95-100.
10
Sodium zirconium cyclosilicate, Revefenacin, and Cannabidiol.环硅酸锆钠、瑞伐非尼和大麻二酚。
J Am Pharm Assoc (2003). 2019 May-Jun;59(3):451-455. doi: 10.1016/j.japh.2019.04.001.
Zotero 插件